86 related articles for article (PubMed ID: 8981687)
1. On the relationship between response to treatment and survival time.
Buyse M; Piedbois P
Stat Med; 1996 Dec; 15(24):2797-812. PubMed ID: 8981687
[TBL] [Abstract][Full Text] [Related]
2. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
3. Surrogate end points for median overall survival in metastatic colorectal cancer: literature-based analysis from 39 randomized controlled trials of first-line chemotherapy.
Tang PA; Bentzen SM; Chen EX; Siu LL
J Clin Oncol; 2007 Oct; 25(29):4562-8. PubMed ID: 17876010
[TBL] [Abstract][Full Text] [Related]
4. Alpha-interferon does not increase the efficacy of 5-fluorouracil in advanced colorectal cancer.
Thirion P; Piedbois P; Buyse M; O'Dwyer PJ; Cunningham D; Man A; Greco FA; Colucci G; Köhne CH; Di Constanzo F; Piga A; Palmeri S; Dufour P; Cassano A; Pajkos G; Pensel RA; Aykan NF; Marsh J; Seymour MT;
Br J Cancer; 2001 Mar; 84(5):611-20. PubMed ID: 11237380
[TBL] [Abstract][Full Text] [Related]
5. The role of stable disease in objective response assessment and its impact on survival in advanced colorectal cancer: is "stable disease" a homogenous response category?
Popov I; Jelić S; Radosavljević D; Nikolić-Tomasević Z
Neoplasma; 1999; 46(2):132-9. PubMed ID: 10466439
[TBL] [Abstract][Full Text] [Related]
6. [Chemotherapy of colorectal carcinoma].
Popov I; Jelić S; Radosavljević D; Nikolić-Tomasević Z
Srp Arh Celok Lek; 1998; 126(11-12):506-11. PubMed ID: 9921027
[TBL] [Abstract][Full Text] [Related]
7. Prognostic and predictive relevance of microsatellite instability in colorectal cancer.
Storojeva I; Boulay JL; Heinimann K; Ballabeni P; Terracciano L; Laffer U; Mild G; Herrmann R; Rochlitz C
Oncol Rep; 2005 Jul; 14(1):241-9. PubMed ID: 15944796
[TBL] [Abstract][Full Text] [Related]
8. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: an updated meta-analysis.
Thirion P; Michiels S; Pignon JP; Buyse M; Braud AC; Carlson RW; O'Connell M; Sargent P; Piedbois P;
J Clin Oncol; 2004 Sep; 22(18):3766-75. PubMed ID: 15365073
[TBL] [Abstract][Full Text] [Related]
9. Should subgroup analysis of randomized clinical trials have a direct impact on clinical practice?
Bria E; Di Maio M; Cuppone F; Nisticò C; Cognetti F; Giannarelli D
J Clin Oncol; 2007 Feb; 25(5):605-6; author reply 606-7. PubMed ID: 17290074
[No Abstract] [Full Text] [Related]
10. Portal vein chemotherapy for colorectal cancer: a meta-analysis of 4000 patients in 10 studies. Liver Infusion Meta-analysis Group.
J Natl Cancer Inst; 1997 Apr; 89(7):497-505. PubMed ID: 9086006
[TBL] [Abstract][Full Text] [Related]
11. A non-parametric procedure for evaluating treatment effect in the meta-analysis of survival data.
Moodie PF; Nelson NA; Koch GG
Stat Med; 2004 Apr; 23(7):1075-93. PubMed ID: 15057879
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors and long-term survivorship in patients with recurrent or metastatic carcinoma of the head and neck.
Argiris A; Li Y; Forastiere A
Cancer; 2004 Nov; 101(10):2222-9. PubMed ID: 15452834
[TBL] [Abstract][Full Text] [Related]
13. Extended follow-up and spatial analysis of the American Cancer Society study linking particulate air pollution and mortality.
Krewski D; Jerrett M; Burnett RT; Ma R; Hughes E; Shi Y; Turner MC; Pope CA; Thurston G; Calle EE; Thun MJ; Beckerman B; DeLuca P; Finkelstein N; Ito K; Moore DK; Newbold KB; Ramsay T; Ross Z; Shin H; Tempalski B
Res Rep Health Eff Inst; 2009 May; (140):5-114; discussion 115-36. PubMed ID: 19627030
[TBL] [Abstract][Full Text] [Related]
14. Is there a case for cisplatin in the treatment of small-cell lung cancer? A meta-analysis of randomized trials of a cisplatin-containing regimen versus a regimen without this alkylating agent.
Pujol JL; Carestia L; Daurès JP
Br J Cancer; 2000 Jul; 83(1):8-15. PubMed ID: 10883661
[TBL] [Abstract][Full Text] [Related]
15. Survival benefit of chemotherapy in metastatic colorectal cancer: a meta-analysis of randomized controlled trials.
Jonker DJ; Maroun JA; Kocha W
Br J Cancer; 2000 Jun; 82(11):1789-94. PubMed ID: 10839292
[TBL] [Abstract][Full Text] [Related]
16. Medical therapy of advanced malignant epithelial tumours of the ovary.
Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
[TBL] [Abstract][Full Text] [Related]
17. Potential and pitfalls of randomized clinical trials in cancer research.
Buyse ME
Cancer Surv; 1989; 8(1):91-105. PubMed ID: 2804990
[TBL] [Abstract][Full Text] [Related]
18. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
[TBL] [Abstract][Full Text] [Related]
19. The influence of the surgeon's and the hospital's caseload on survival and local recurrence after colorectal cancer surgery.
Renzulli P; Lowy A; Maibach R; Egeli RA; Metzger U; Laffer UT
Surgery; 2006 Mar; 139(3):296-304. PubMed ID: 16546492
[TBL] [Abstract][Full Text] [Related]
20. HER2 status and efficacy of adjuvant anthracyclines in early breast cancer: a pooled analysis of randomized trials.
Gennari A; Sormani MP; Pronzato P; Puntoni M; Colozza M; Pfeffer U; Bruzzi P
J Natl Cancer Inst; 2008 Jan; 100(1):14-20. PubMed ID: 18159072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]